NCT00454818

Timeline

Start date

Mar 1, 2007

Primary completion

Aug 1, 2010

Completion date

Aug 1, 2012

First posted

—

Last posted

—

Enrollment

51

Arms / groups

5 / —

Source

AACT · pre-existing

Sponsors

• Celladon CorporationLead sponsor
• Allegiance HealthOverall official - principal investigator
• University of PennsylvaniaOverall official - principal investigator
• University of PittsburghOverall official - principal investigator
• University of ChicagoOverall official - principal investigator
• Northwestern UniversityOverall official - principal investigator
• University of CincinnatiOverall official - principal investigator
• Wake Forest UniversityOverall official - principal investigator
• University of WisconsinOverall official - principal investigator
• Oregon Health and Science UniversityOverall official - principal investigator
• University of Medicine and Dentistry of New JerseyOverall official - principal investigator
• Case Western Reserve UniversityOverall official - principal investigator
• San Diego Cardiac CenterOverall official - principal investigator
• Columbia UniversityOverall official - principal investigator
• University of California, San DiegoOverall official - principal investigator
• University of FloridaOverall official - principal investigator
• Saint Luke's Health SystemOverall official - principal investigator
• University of PennsylvaniaStudy chair
• Tennessee Center for Clinical TrialsOverall official - principal investigator
• Medical City Children's Hospital, DallasOverall official - principal investigator
• St. Louis UniversityOverall official - principal investigator
• Icahn School of Medicine at Mount SinaiOverall official - principal investigator
• University of RochesterOverall official - principal investigator
• Methodist Cancer Center, Houston, TexasOverall official - principal investigator

Drugs studied

• mydicar

Indications studied

• Cardiomyopathy, Dilated
• Heart Failure